본문 영역으로 바로가기

업계소식

Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties

조회수 12

[ 기사일자 ]
Fri, 05 Sep 2025 12:30:00 +0900

[ 기사내용 ]
9% (28 patients), including a complete response (CR) rate of 8.97% and a partial response (PR)... In a combination trial with standard of care, Pluvicto achieved an ORR of 29.8%, with a CR rate...

[ 원문기사 상세보기 ]
http://www.edaily.co.kr/news/newspath.asp?newsid=02545286642297168

목록보기

TOP